Defining vascular anomaly phenotypes in children based on a systematic literature search: A critical step in

Laurence Gariépy-Assal1, Josée Dubois2,3,4,5, Kelley Zwicker4,6

  • 1Pediatric Residency Program, CHU Sainte-Justine, Université de Montréal, Montréal, Quebec, Canada.

Insights

This study identified two main clinical phenotypes in children with vascular anomalies (VA). These distinct systemic and functional phenotypes could form the basis for a unified VA severity scoring system.

Area of Science:

  • Vascular biology and medicine
  • Pediatric genetics and therapeutics

Background:

  • Genetically targeted drugs are used for vascular anomalies (VA) without a validated severity score.
  • Accurate VA severity assessment is crucial for guiding treatment decisions.

Purpose of the Study:

  • To evaluate the feasibility of a unified severity score for VA.
  • To group distinct clinical characteristics of VA into a single assessment tool.

Main Methods:

  • Systematic literature review of children treated with sirolimus for VA.
  • Extraction of demographic data and clinical features to define phenotypes.

Main Results:

  • Vascular anomalies (VA) present with two primary, potentially overlapping phenotypes: systemic and functional.
  • Systemic phenotype: invasion of vital structures, hospitalization, and aggressive infant management.
  • Functional phenotype: chronic pain and disability in adolescence, managed outpatient.

Conclusions:

  • The identified systemic and functional phenotypes provide a foundation for a unified VA severity scoring system.
  • A validated scoring system could improve the management of pediatric vascular anomalies.
Abstract